Microbot Medical Inc. Financial Ratios — MBOT Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-162.78	-230.61	-182.73	-314.45	- -	- -	-103.04	-124.07	-44.09	-32.84	-58.48	-121.53	-182.19	-284.97	-32.42
Return on Assets (%)	-76.44	-102.9	-73.72	-88.51	-5.59	-495.92	-105.49	-84.86	-33.54	-28.92	-52.56	-100.12	-120.24	-159.4	-30.01
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	82.4	46.26	-83.77	100	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-2,123.95	-4,198.42	-15,654.44	-2,924.08	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-2,222.9	-4,400.93	-16,268.92	-3,053.2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	-2,962.82	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,747.28	-5,711.72	-15,082.5	-3,186.58	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-1,747.28	-5,817.88	-15,345.11	-3,234.05	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-1,747.28	-5,817.88	-15,345.11	-3,234.05	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	-64.17	-69.26	-26.34	-3.63	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-162.78	-230.61	-182.73	-314.45	- -	- -	-130.17	-128.56	-44.09	-32.84	-58.48	-121.53	-182.19	-284.97	-32.42

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1	- -	13	15	2	- -	- -	- -	1	1	1	- -	- -	- -	1
ST Debt	- -	- -	4	5	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	9	10	- -	- -	- -	- -	1	1	- -	- -	- -	- -	1
Total Debt/EBITDA	-0.02	-0.02	-0.49	-0.51	-2.07	-0.01	- -	- -	-0.13	-0.09	-0.06	-0.03	-0.02	-0.01	-0.06
Net Debt/EBITDA	0.49	0.4	0.65	0.34	-1.56	0.27	2.06	0.73	4.02	2.18	1.2	0.18	0.25	0.27	0.27
Total Debt/EBIT	-0.02	-0.02	-0.47	-0.49	-2.03	-0.01	- -	- -	-0.12	-0.09	-0.06	-0.03	-0.02	-0.01	-0.06
Net Debt/EBIT	0.47	0.38	0.63	0.32	-1.53	0.27	2.05	0.72	3.97	2.16	1.19	0.18	0.24	0.27	0.27
EBITDA to Interest Expense	-363.3	-409.63	-23.12	-22.85	-1.77	-28.82	-22.04	-449.38	-69.48	-112.76	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-367.46	-411.08	-27.13	-23.55	-1.78	-28.89	-22.29	-463.31	-71.57	-113.9	- -	- -	- -	- -	- -
EBIT to Interest Expense	-380.23	-429.38	-24.02	-23.86	-1.81	-28.85	-22.13	-452.75	-70.29	-113.61	- -	- -	- -	- -	- -
Interest Expense	- -	- -	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	42.55	46.35	35.98	18.1	-28.54	50.36	90.42	21.84	84.95	92.5	85.77	76.43	54.05	58.53	95.11
Long-Term Debt/Equity (%)	3.09	0.98	62.02	176.18	- -	4.48	- -	- -	2.41	2.58	2.8	2.46	0.89	1.16	0.73
Long-Term Debt/Capital (%)	2.94	0.96	33.08	49.44	23.38	4.29	- -	- -	2.34	2.49	2.67	2.31	0.85	1.13	0.73
Long-Term Debt/Total Assets (%)	1.31	0.46	22.32	31.9	79.21	2.26	- -	- -	2.05	2.38	2.4	1.88	0.48	0.68	0.7
Total Debt/Equity (%)	5.04	2.51	87.5	256.35	-2,900.66	4.48	- -	- -	2.86	3.34	4.73	6.34	5.13	3.14	1.12
Total Debt/Capital (%)	4.8	2.45	46.67	71.94	103.57	4.29	- -	- -	2.78	3.24	4.51	5.96	4.88	3.05	1.1
Total Debt/Total Assets (%)	2.14	1.16	31.49	46.41	350.93	2.26	- -	- -	2.43	3.09	4.06	4.84	2.77	1.84	1.06
Net Debt to Equity	-119.24	-58.21	-117.37	-169.78	-2,186.54	-155.25	-108.26	-393.83	-91.22	-80.84	-93.83	-33.5	-54.83	-88.22	-5.04
Net Debt/Capital (%)	625.17	-138.81	689.17	245.08	103.24	281	1,310.69	134.03	-783.52	-359.17	-860.52	-46	-109.01	-590.89	-5.25
EBITDA	-26	-21	-27	-30	-1	-10	-5	-7	-7	-9	-11	-13	-10	-12	-15
EBITDA-CapEx	-26	-21	-32	-31	-1	-10	-5	-7	-7	-9	-11	-13	-10	-12	-15
Operating Income (Loss)	-27	-22	-28	-31	-1	-10	-5	-7	-7	-9	-11	-13	-10	-12	-15

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.93	4.39	3.35	2.17	2.51	3.46	20.43	1.1	6.48	18.33	7.81	3.97	1.69	2.22	22.97
Current Ratio	3.08	4.72	3.49	2.31	2.82	4.23	20.7	1.23	7.45	18.78	8	4.26	2.09	2.37	23.33
Quick Ratio	2.98	4.45	3.41	2.21	2.68	3.48	20.5	1.11	6.5	18.58	7.9	4.22	2.08	2.35	23.16
CFO/Avg Current Liab	-3.95	-3.7	-3.28	-2.65	-0.13	-1.64	-7.41	-2.01	-1.35	-2.35	-5.62	-5.7	-2.91	-2.83	-4.44
Common Equity/Total Assets	42.55	46.35	35.98	18.1	-28.54	50.36	90.42	21.84	84.95	92.5	85.77	76.43	54.05	58.53	95.11
Long-Term Debt/Equity (%)	3.09	0.98	62.02	176.18	- -	4.48	- -	- -	2.41	2.58	2.8	2.46	0.89	1.16	0.73
Long-Term Debt/Capital (%)	2.94	0.96	33.08	49.44	23.38	4.29	- -	- -	2.34	2.49	2.67	2.31	0.85	1.13	0.73
Long-Term Debt/Total Assets (%)	1.31	0.46	22.32	31.9	79.21	2.26	- -	- -	2.05	2.38	2.4	1.88	0.48	0.68	0.7
Total Debt/Equity (%)	5.04	2.51	87.5	256.35	-2,900.66	4.48	- -	- -	2.86	3.34	4.73	6.34	5.13	3.14	1.12
Total Debt/Capital (%)	4.8	2.45	46.67	71.94	103.57	4.29	- -	- -	2.78	3.24	4.51	5.96	4.88	3.05	1.1
Total Debt/Total Assets (%)	2.14	1.16	31.49	46.41	350.93	2.26	- -	- -	2.43	3.09	4.06	4.84	2.77	1.84	1.06
CFO/Total Liabilities	-152.33	-122.76	-87.67	-103	-129.01	-47.01	-459.85	-111.55	-115.49	-367.94	-392.04	-513.75	-223.03	-352.94	-326.97
CFO/CapEx	-74.29	-271.87	-4.98	-30.26	-382.5	-31.44	-83.72	-23.81	-29.87	-79.69	-135.57	-137.49	-258.58	-353.08	-217.43
Altman's Z-Score	-24.58	-18.72	-14.64	-19.48	31.72	44.16	20.46	-9.47	6.89	12.5	7.52	-7.56	-13.78	-21.59	18.94

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	14.08	5.95	1.57	7.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	25.93	61.37	231.94	48.36	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.33	1.24	1.32	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.73
Accounts Payable Turnover Days	1,109.41	293.85	277.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	211.25
Cash Conversion Cycle	-1,083.48	-232.47	-45.17	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	25.93	61.37	231.94	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	18	61	68	65	46	162	41	5	73	49	53	24	19	22	134
- Cash & Cash Equivalents	13	8	31	25	- -	3	11	5	29	20	13	2	2	3	4
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	- -	13	15	2	- -	- -	- -	1	1	1	- -	- -	- -	1
Enterprise Value	2	39	50	55	48	159	31	- -	43	25	38	16	13	16	57
Total Capital	11	14	28	21	2	2	10	1	32	25	15	8	5	4	78
Total Debt/Capital (%)	4.8	2.45	46.67	71.94	103.57	4.29	- -	- -	2.78	3.24	4.51	5.96	4.88	3.05	1.1
Total Debt / EV	0.22	0.01	0.26	0.28	0.04	- -	- -	- -	0.02	0.03	0.02	0.03	0.02	0.01	0.02
EV/Sales	2	79.93	292.24	53.96	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	12	47	53	58	40	87	33	5	43	49	53	22	17	18	92
Diluted Enterprise Value	-1	39	36	48	41	85	23	- -	16	30	40	20	14	15	89
EV per Share	176.1	1,690.76	1,479.41	1,287.7	696.99	90.01	11.31	- -	5.94	3.54	5.42	2.03	1.11	0.84	0.84
TTM Sales	1	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-26	-21	-27	-30	-1	-10	-5	-7	-7	-9	-11	-13	-10	-12	-15
TTM Operating Income	-27	-22	-28	-31	-1	-10	-5	-7	-7	-9	-11	-13	-10	-12	-15
TTM Cash Flow to Firm	-22	-20	-22	-26	- -	- -	-5	-5	-6	-7	-9	-12	-9	-9	-13
TTM Free Cash Flow to Firm	-22	-20	-17	-25	- -	- -	-5	-5	-6	-7	-9	-11	-8	-9	-13

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-0.54	-2.37	-2.87	-2.19	-52.32	-114.58	-6.95	-0.98	-6.96	-6.85	-5.74	-1.91	-1.97	-1.99	-7.05
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	2	39	50	55	48	159	31	- -	43	25	38	16	13	16	57
Low Price	1,134.57	956.28	1,880.14	1,361.48	502.45	44.55	15	1.38	1.62	4.3	4.31	3	1	0.82	1.11
EV/Sales	2	79.93	292.24	53.96	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-3.49	-1.37	-2.66	-2.66	-116.63	-44.38	-16.04	-3.94	-3.83	-5.83	-4.68	-2.85	-2.01	-1.45	-8.44
Price/Earnings High	-7.52	-2.7	-3.5	-4.58	-237.5	-121.74	-54.08	-7.15	-11.86	-12.23	-6.72	-4.36	-4.15	-3.21	-16.27
Price/Earnings Low	-0.47	-0.6	-1.91	-1.58	-52.97	-7.44	-5.44	-0.57	-0.95	-3.34	-2.71	-1.65	-0.95	-1.12	-3.87
Price/Book Value	1.72	4.37	4.54	11	-307.28	95.5	4.15	3.9	2.32	2.01	3.71	3.26	4.27	6.16	1.73
Price/Book Value Average	10.98	3.62	5.97	16.53	-503.61	277.5	12.01	21.52	1.48	2.2	3.68	5.6	5.5	5.83	2.1
Price/Book Value High	23.64	7.16	7.86	28.46	-1,025.5	761.21	40.49	39.07	4.59	4.61	5.28	8.56	11.37	12.91	4.04
Price/Book Value Low	1.46	1.58	4.28	9.84	-228.71	46.5	4.07	3.13	0.37	1.26	2.13	3.25	2.6	4.51	0.96
Price/Tangible Book Value	2.71	6.01	6.18	11.71	-235.75	95.5	4.15	3.9	2.32	2.01	3.71	3.26	4.27	6.16	1.73
Price/Tangible Book Value Average	17.26	4.98	8.14	17.6	-386.37	277.5	12.01	21.52	1.48	2.2	3.68	5.6	5.5	5.83	2.1
Price/Tangible Book Value High	37.19	9.84	10.7	30.3	-786.78	761.21	40.49	39.07	4.59	4.61	5.28	8.56	11.37	12.91	4.04
Price/Tangible Book Value Low	2.3	2.18	5.83	10.48	-175.47	46.5	4.07	3.13	0.37	1.26	2.13	3.25	2.6	4.51	0.96
Price/Sales	9.58	95.98	310.13	57.17	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	61	79.48	408.32	85.94	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	131.39	157.23	537.05	147.96	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	8.14	34.74	292.48	51.15	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	-0.53	-2.37	-2.29	-2.12	-52.19	-110.93	-6.86	-0.94	-6.73	-6.76	-5.7	-1.89	-1.96	-1.99	-7.02
Price/Cash Flow Average	-3.38	-1.96	-3.02	-3.18	-85.53	-322.36	-19.84	-5.2	-4.31	-7.38	-5.66	-3.25	-2.53	-1.88	-8.5
Price/Cash Flow High	-7.27	-3.88	-3.97	-5.48	-174.17	-884.25	-66.9	-9.43	-13.33	-15.46	-8.12	-4.97	-5.22	-4.17	-16.39
Price/Cash Flow Low	-0.45	-0.86	-2.16	-1.89	-38.84	-54.01	-6.73	-0.75	-1.07	-4.22	-3.28	-1.89	-1.2	-1.45	-3.9
Price/Free Cash Flow Average	-3.42	-1.97	-3.77	-3.29	-85.76	-332.95	-20.08	-5.42	-4.46	-7.47	-5.7	-3.28	-2.54	-1.88	-8.54
Price/Free Cash Flow High	-7.37	-3.89	-4.96	-5.66	-174.62	-913.3	-67.71	-9.85	-13.79	-15.65	-8.18	-5.01	-5.24	-4.18	-16.47
Price/Free Cash Flow Low	-0.46	-0.86	-2.7	-1.96	-38.94	-55.79	-6.81	-0.79	-1.11	-4.27	-3.3	-1.9	-1.2	-1.46	-3.91
EV/Sales Average	85.97	86.84	416.93	86.05	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	197.26	188.01	580.39	155.23	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	2.41	28.63	269.83	47.24	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-4.05	-2.07	-2.66	-2.94	-86.36	-48.62	-20.75	-3.25	-2.64	-3.83	-3.56	-2.91	-2.24	-1.52	-10.86
EV/EBITDA High	-9.29	-4.48	-3.71	-5.31	-174.12	-133.86	-74.84	-6.5	-16.34	-10.32	-5.6	-4.53	-4.88	-3.69	-21.13
EV/EBITDA Low	-0.11	-0.68	-1.72	-1.62	-40.14	-7.92	-5.68	0.15	2.27	-1.3	-1.58	-1.63	-0.94	-1.12	-4.87
EV/EBIT Average	-3.87	-1.97	-2.56	-2.82	-84.76	-48.57	-20.67	-3.23	-2.61	-3.8	-3.53	-2.89	-2.22	-1.51	-10.83
EV/EBIT High	-8.87	-4.27	-3.57	-5.08	-170.88	-133.72	-74.54	-6.45	-16.15	-10.24	-5.56	-4.5	-4.83	-3.66	-21.07
EV/EBIT Low	-0.11	-0.65	-1.66	-1.55	-39.39	-7.91	-5.66	0.15	2.24	-1.29	-1.57	-1.61	-0.93	-1.11	-4.85
Last Price	1,335.55	2,641.92	1,993.6	1,521.94	675.07	91.5	15.3	1.72	10.17	6.89	7.5	3.01	1.64	1.12	2
High Price	18,315.15	4,327.56	3,452.33	3,938.57	2,252.93	729.36	149.1	17.25	20.15	15.75	10.69	7.91	4.37	2.35	4.67
Enterprise Value Average	105	43	72	87	78	468	109	23	19	35	40	39	22	18	160
Enterprise Value High	241	92	100	157	156	1,288	393	47	117	93	63	60	49	43	311
Enterprise Value Low	3	14	46	48	36	76	30	-1	-16	12	18	22	9	13	71

Shares Outstanding	- -	- -	- -	- -	- -	2	3	3	7	7	7	8	12	19	67
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	1	2	3	4	7	7	7	10	16	46
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1	2	3	4	7	7	7	10	16	46
Revenue per Share	139.39	27.52	6.43	26.62	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-2,960.65	-1,155.6	-1,006.31	-778.37	-15.18	-10.1	-2.41	-2.48	-1.68	-1.27	-1.59	-1.84	-0.98	-0.74	-0.32
Operating Income per Share	-3,098.58	-1,211.34	-1,045.81	-812.74	-15.47	-10.11	-2.42	-2.49	-1.7	-1.28	-1.6	-1.85	-0.99	-0.74	-0.32
Basic EPS, GAAP	-2,435.6	-1,601.35	-986.43	-860.89	-9.49	-5.99	-2.76	-2.41	-1.7	-1.29	-1.59	-1.81	-1.05	-0.73	-0.29
Basic EPS from Cont Ops	-2,435.6	-1,572.13	-969.54	-848.25	-15.57	-10.14	-3.48	-2.5	-1.7	-1.29	-1.59	-1.81	-1.05	-0.73	-0.29
Diluted EPS, GAAP	-2,435.6	-1,601.35	-986.43	-860.89	-9.49	-5.99	-2.76	-2.41	-1.7	-1.29	-1.59	-1.81	-1.05	-0.73	-0.29
Diluted EPS from Cont Ops	-2,435.6	-1,572.13	-969.54	-848.25	-15.57	-10.14	-3.48	-2.5	-1.7	-1.29	-1.59	-1.81	-1.05	-0.73	-0.29
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2,518.93	-1,116.76	-870.13	-719.2	-12.94	-0.82	-2.23	-1.83	-1.51	-1.02	-1.32	-1.59	-0.84	-0.56	-0.28
Free Cash Flow per Basic Share	-2,552.84	-1,120.86	-1,044.76	-742.96	-12.97	-0.85	-2.26	-1.91	-1.56	-1.03	-1.33	-1.6	-0.84	-0.57	-0.29
Cash & Equivalents per Share	1,198.49	966.31	898.65	588.98	6.36	1.53	3.99	1.74	4.35	3.47	2.18	1.04	0.55	0.28	1.17
Book Value per Share	774.71	604.03	439.36	138.38	-2.2	0.96	3.68	0.44	4.39	3.42	2.02	0.92	0.38	0.18	1.15
Tangible Book Value per Share	492.53	439.63	322.57	129.97	-2.86	0.96	3.68	0.44	4.39	3.42	2.02	0.92	0.38	0.18	1.15

Microbot Medical Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)